CC
PRCT icon

Chicago Capital’s Procept Biorobotics PRCT Stock Holding History

Chicago Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.8M Sell
2,073,237
-87,350
-4% -$2.19M 1.13% 30
2026
Q1 		$54M Buy
2,160,587
+969,592
+81% +$27.3M 1.46% 23
2025
Q4 		$37.5M Sell
1,190,995
-377,850
-24% -$12.5M 0.93% 34
2025
Q3 		$56M Buy
1,568,845
+999,873
+176% +$45.7M 1.38% 27
2025
Q2 		$32.8M Buy
568,972
+146,599
+35% +$8.29M 0.81% 40
2025
Q1 		$24.6M Buy
422,373
+42,791
+11% +$2.92M 0.7% 40
2024
Q4 		$30.6M Buy
379,582
+116,931
+45% +$9.99M 0.81% 39
2024
Q3 		$21M Buy
262,651
+29,668
+13% +$2.11M 0.58% 44
2024
Q2 		$14.2M Buy
+232,983
New +$13.9M 0.42% 49

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Chicago Capital's PRCT Position: Q2 2026 in Review

Chicago Capital reduced its Procept Biorobotics (PRCT) stake by 4% in Q2 2026, selling an estimated $2.19M and leaving 2,073,237 shares worth $46.8M. The position accounts for 1.13% of the portfolio, ranked #30.

Chicago Capital first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $56M in Q3 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Chicago Capital held 2,073,237 shares of Procept Biorobotics worth $46.8M as of Q2 2026.
  • Chicago Capital sold 87,350 Procept Biorobotics shares in Q2 2026, an estimated $2.19M.
  • Procept Biorobotics made up 1.13% of Chicago Capital's portfolio in Q2 2026, its #30 holding.
  • Chicago Capital first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
  • Chicago Capital's Procept Biorobotics position peaked at $56M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.